j biol chem impact factor 2004

part of our festivities, we invite you to send your best wishes, share photos and record your fondest memories of interactions with him over the years. Dong B, et al, strong induction of pcsk9 gene expression through HNF1alpha and srebp2:mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters. Altered Metabolism of Low-density Lipoprotein and Very Low-density Lipoprotein Remnant in Autosomal Recessive Hypercholesterolemia: Results from Stable Isotope Kinetic Study in vivo. Measurement of serum remnant-like lipoprotein particle-triglyceride (RLP-TG) and RLP-TG/total TG ratio using highly sensitive triglyceride assay reagent.

Nagano N,. Namekata K,et al, abnormal lipid metabolism in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia. Your browser will take you to a Web page (URL) associated with that DOI name. Antonia Seymour, Publishing Director, said: "IOP Publishing is all about delivering impact, recognition and value to the scientific community.

Liposearch, araki E, et al, effects of Pemafibrate, a Novel Selective ppar Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial. This excellent set of Journal Impact Factor results demonstrates that commitment to the researchers we serve. Endocrinology, 2012; 153(7, tada H,. Biol Chem, 2004; 279(51. J Atheroscler Thromb, 2012; 19(1 36-46. Without the unfailing support and hard work of our many authors, referees, editorial boards and society partners, IOP Publishing's continued growth and success would not be possible. Diabetes Care 2018;41(3 538-546. LDL : Journal of Japan Society for the Study of Obesity 14(1 64-71. Ishibashi S, et al, effects of K-877, a novel selective ppar modulator (spparm in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial. Journals published by IOP publishing have made significant gains in the 2017 Journal Impact Factors, published by Clarivate Analytics, with over 60 the portfolio achieving an increase on the previous year. Early postnatal changes of lipoprotein subclass profile in late preterm infants. Revista Peruara Cardiol, 2006; 32(2 129-144.